Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Incretin based investigational therapies for the treatment of MASLD MASH Diabetes Research and Clinical Practice High Quality High quality Cagrilintide API Powder Manufacture and Factory Apino Pharma Clinical trials of subcutaneous tirzepatide, retatrutide, and Download Scientific Diagram The evolving landscape of obesity pharmacotherapy Nature Reviews Drug Discovery, 2026 1 Obesity pharmacotherapy has moved from weight loss drugs to cardiometabolic disease modifying therapy Obesity is now framed as a chronic, relapsing, Edmonds Peptides (PC)